Cancer Vaccines
U.S. Patent Office Upholds Key Human Embryonic Stem Cell Patent
Published in Vaccine Weekly, March 12th, 2008
Geron Corporation (Nasdaq:GERN) announced that the U.S. Patent Office has upheld the validity of a key patent for human embryonic stem cells. The patent is assigned to the Wisconsin Alumni Foundation ("WARF") and is one of three related patents challenged through reexamination proceedings. Geron holds an exclusive license under these patents to develop and commercialize therapies based on three types of cells derived from human embryonic stem cells: neural cells, cardiomyocytes and pancreatic islet cells.
In communicating its decision, the Patent Office issued an 82 page Action Closing Prosecution in the inter-partes reexamination of U.S. Patent Number 7,029,913. The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2008-03-12)
More Articles from Vaccine Weekly
- DNA Vaccines
New findings from Y.Z. Yu and co-researchers in the area of DNA vaccines described - DNA Vaccines
Scientists at Centers for Disease Control and Prevention report research in DNA vaccines - Flu Vaccines
Influenza Vaccination Rates Among Health Care Personnel Remain Well Below National Goal - HIV/AIDS
New research on HIV/AIDS from L.X. Liu and co-authors summarized - HIV/AIDS
Scientists at Columbia University target HIV/AIDS - Malaria
Studies from University of Massachusetts have provided new information about malaria - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
